Gene Review:
Vav2 - vav 2 oncogene
Mus musculus
Synonyms:
2810040F13Rik, AI847175, Guanine nucleotide exchange factor VAV2, VAV-2
- Loss of Vav2 proto-oncogene causes tachycardia and cardiovascular disease in mice. Sauzeau, V., Jerkic, M., López-Novoa, J.M., Bustelo, X.R. Mol. Biol. Cell (2007)
- Compensation between Vav-1 and Vav-2 in B cell development and antigen receptor signaling. Tedford, K., Nitschke, L., Girkontaite, I., Charlesworth, A., Chan, G., Sakk, V., Barbacid, M., Fischer, K.D. Nat. Immunol. (2001)
- Signal transduction through Vav-2 participates in humoral immune responses and B cell maturation. Doody, G.M., Bell, S.E., Vigorito, E., Clayton, E., McAdam, S., Tooze, R., Fernandez, C., Lee, I.J., Turner, M. Nat. Immunol. (2001)
- Vav2 is an activator of Cdc42, Rac1, and RhoA. Abe, K., Rossman, K.L., Liu, B., Ritola, K.D., Chiang, D., Campbell, S.L., Burridge, K., Der, C.J. J. Biol. Chem. (2000)
- Isolation and characterization of murine vav2, a member of the vav family of proto-oncogenes. Schuebel, K.E., Bustelo, X.R., Nielsen, D.A., Song, B.J., Barbacid, M., Goldman, D., Lee, I.J. Oncogene (1996)
- Phosphorylation-dependent and constitutive activation of Rho proteins by wild-type and oncogenic Vav-2. Schuebel, K.E., Movilla, N., Rosa, J.L., Bustelo, X.R. EMBO J. (1998)
- Differential requirements for Vav proteins in DAP10- and ITAM-mediated NK cell cytotoxicity. Cella, M., Fujikawa, K., Tassi, I., Kim, S., Latinis, K., Nishi, S., Yokoyama, W., Colonna, M., Swat, W. J. Exp. Med. (2004)
- Vav1 and Vav2 play different roles in macrophage migration and cytoskeletal organization. Wells, C.M., Bhavsar, P.J., Evans, I.R., Vigorito, E., Turner, M., Tybulewicz, V., Ridley, A.J. Exp. Cell Res. (2005)
- Vav proteins are required for B-lymphocyte responses to LPS. Hebeis, B., Vigorito, E., Kovesdi, D., Turner, M. Blood (2005)
- Tyrosine phosphorylation mediates both activation and downmodulation of the biological activity of Vav. López-Lago, M., Lee, H., Cruz, C., Movilla, N., Bustelo, X.R. Mol. Cell. Biol. (2000)